[Federal Register Volume 74, Number 63 (Friday, April 3, 2009)]
[Notices]
[Pages 15313-15314]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-7497]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: NRC will convene a meeting of the Advisory Committee on the 
Medical Uses of Isotopes (ACMUI) on May 7-8, 2009. A sample of agenda 
items to be discussed during the public session includes: (1) Summary 
of the enforcement process and enforcement actions against medical 
licensees; (2) regulatory responsibilities of the U.S. Food and Drug 
Administration; (3) ACMUI subcommittee report on byproduct material 
events; (4) ACMUI subcommittee report on training and experience for 
yttrium-90 microspheres users; (5) National Academy of Science report 
on the production of medical isotopes using highly enriched uranium and 
low enriched uranium; (6) briefing on the Veterans Affairs medical 
events; (7) infiltrations of therapeutic radiopharmaceuticals as 
medical events; (8) National Council on Radiation Protection & 
Measurements Report 160 ``Ionizing Radiation Exposure of the Population 
of the United States'' and its implications for NRC programs; (9) ACMUI 
subcommittee report on training and experience for American Board of 
Radiology certification; (10) medical event reporting to the 
International Nuclear Event Scale; and (11) potential changes to 10 CFR 
Part 35. A copy of the agenda will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/agenda or by e-mailing Ms. Ashley 
Cockerham at the contact information below.
    Purpose: Discuss issues related to 10 CFR Part 35 Medical Use of 
Byproduct Material.
    Date and Time for Closed Session: May 7, 2009, from 3:15 p.m. to 
5:30 p.m. This session will be closed so that ACMUI can complete self-
evaluations, discuss internal Committee business, and prepare for a 
meeting with the Commission.

[[Page 15314]]

    Date and Time for Open Sessions: May 7, 2009, from 8 a.m. to 3:15 
p.m. and May 8, 2009, from 8 a.m. to 4:30 p.m.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two 
White Flint North Auditorium, 11545 Rockville Pike, Rockville, Maryland 
20852.
    Public Participation: Any member of the public who wishes to 
participate in the meeting should contact Ms. Cockerham using the 
information below.
    Contact Information: Ashley M. Cockerham, e-mail: 
[email protected], telephone: (240) 888-7129.
    Conduct of the Meeting: Leon S. Malmud, M.D., will chair the 
meeting. Dr. Malmud will conduct the meeting in a manner that will 
facilitate the orderly conduct of business. The following procedures 
apply to public participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Cockerham at the contact information listed 
above. All submittals must be received by April 30, 2009, and must 
pertain to the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript will be available on ACMUI's Web site 
(http://www.nrc.gov/reading-rm/doc-collections/acmui/tr/) on or about 
June 8, 2009. A meeting summary will be available on ACMUI's Web site 
(http://www.nrc.gov/reading-rm/doc-collections/acmui/meeting-summaries/
) on or about June 22, 2009.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Cockerham of their planned 
attendance.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, Part 7.

    Dated: March 30, 2009.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. E9-7497 Filed 4-2-09; 8:45 am]
BILLING CODE 7590-01-P